FitLife Brands, Inc.
- Open
- 11.08
- Day high
- 11.11
- Day low
- 11.00
- Prev close
- 11.16
- Volume
- 7K
- Mkt cap
- $104M
- P/E (TTM)
- 17.3
- EPS (TTM)
- $0.64
- P/B
- 2.3
- P/S
- 1.1
- Yield
- —
- Per share
- —
- ▲Insiders net buying $3K over the last 3 months (1 open-market buy, 0 sales)
- 🏛Institutions accumulating (13F)
FitLife Brands, Inc. (FTLF) is a Consumer Defensive company listed on NASDAQ. The stock is down 13% over the past year. Over the trailing 3 months, insiders filed 1 open-market buy and 0 sales (SEC Form 4).
FitLife Brands, Inc. (FTLF) financials & analyst ratings
Fundamentals (TTM)
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
FTLF earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 14, 2026 | $0.14 | $0.17 | +21.4% | $25M | +1.8% |
| Mar 31, 2026 | $0.25 | $0.25 | +0.0% | $26M | -4.0% |
| Nov 13, 2025 | $0.25 | $0.19 | -24.0% | $23M | -1.6% |
| Aug 14, 2025 | $0.18 | $0.18 | +0.0% | $16M | -3.0% |
| May 15, 2025 | $0.24 | $0.20 | -16.7% | $16M | -11.0% |
| Mar 27, 2025 | $0.23 | $0.15 | -34.8% | $15M | -14.6% |
| Nov 14, 2024 | $0.25 | $0.23 | -8.0% | $16M | +3.7% |
| Aug 14, 2024 | — | $0.26 | — | $17M | — |
| Mar 29, 2024 | — | $0.15 | — | $13M | — |
| Aug 14, 2023 | — | $0.45 | — | $15M | — |
| May 15, 2023 | — | $0.25 | — | $11M | — |
| Nov 10, 2022 | — | $0.12 | — | $8M | — |
FTLF insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 19, 2026 | Hansen Ryan P.officer: President | Grant | 28,500 | $10.50 |
| May 19, 2026 | Hansen Ryan P.officer: President | Grant | 50,000 | — |
| May 19, 2026 | Hansen Ryan P.officer: President | Grant | 46,500 | $10.50 |
| Apr 20, 2026 | Yakatan Sethdirector | Buy | 164 | $15.36 |
| Apr 14, 2026 | Lingenbrink Matthewdirector | Buy | 3,000 | $9.76 |
| Apr 14, 2026 | Dawson Grant Robertdirector | Buy | 3,000 | $9.98 |
| Sep 8, 2025 | York Jakobofficer: CHIEF FINANCIAL OFFICER | Grant | 4,000 | $18.73 |
| Apr 16, 2025 | Ordal Todddirector | Buy | 300 | $12.07 |
| Apr 16, 2025 | Lingenbrink Matthewdirector | Buy | 3,000 | $12.17 |
| Apr 2, 2025 | Lingenbrink Matthewdirector | Buy | 2,800 | $12.17 |
| Apr 2, 2025 | Dayton Judddirector, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Option | 144,000 | $2.62 |
| Mar 28, 2025 | Dawson Grant Robertdirector | Grant | 2,144 | $12.68 |
| Jan 16, 2025 | Ordal Todddirector | Buy | 150 | $30.37 |
| Jan 2, 2025 | Dayton Judddirector, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | Option | 6,200 | $0.70 |
| Sep 3, 2024 | York Jakobofficer: CHIEF FINANCIAL OFFICER | Grant | 2,000 | $33.20 |
Source: FTLF SEC Form 4 filings, latest May 19, 2026. For informational purposes only — not investment advice.
See the full FTLF insider & 13F page →FitLife Brands, Inc. company profile
Overview
FitLife Brands, Inc. (NASDAQ:FTLF) is a nutritional supplement company that has evolved through strategic acquisitions to become a diversified player in the health and wellness market. Originally incorporated as Bond Laboratories in 2005 and rebranded as FitLife Brands in 2013, the company went public in 2007. Based in Omaha, Nebraska, FitLife has transformed from a single-brand operation into a multi-brand portfolio company through acquisitions of established supplement brands including MusclePharm, Mimi's Rock Corp, and several others. The company operates primarily in the United States with some international presence, focusing on direct-to-consumer online sales while maintaining wholesale distribution channels.
Business
FitLife Brands operates in the nutritional supplements industry, which encompasses products designed to support various health and fitness goals. The nutritional supplement market includes vitamins, minerals, protein powders, weight loss aids, and specialized formulations for athletic performance. These products are typically sold as powders, capsules, bars, and ready-to-drink beverages that consumers use to supplement their regular diet. The company operates through three main business segments. Legacy FitLife brands represent approximately 45% of total revenue and include NDS Nutrition, PMD Sports, SirenLabs, CoreActive, and others, focusing on weight loss, general health, and sports nutrition supplements. These products are sold through both wholesale channels (about 63% of segment revenue) and online direct-to-consumer sales (37%). Mimi's Rock Corp (MRC) contributes roughly 42% of total revenue and primarily consists of the Dr. Tobias brand, which specializes in digestive health, general wellness supplements, and some skincare products. This segment operates almost entirely through online sales channels, particularly Amazon, where it has built a substantial subscriber base. MusclePharm represents about 13% of revenue and focuses on sports nutrition products, particularly protein powders, bars, and performance supplements targeted at serious fitness enthusiasts and professional athletes. The company acquired MusclePharm's assets through bankruptcy proceedings and is working to rebuild the brand's market presence. The nutritional supplement industry serves health-conscious consumers who seek to optimize their nutrition, support fitness goals, manage weight, or address specific health concerns through targeted supplementation. Products range from basic vitamins to specialized formulations for muscle building, weight management, and athletic performance enhancement.
Revenue model
FitLife Brands generates revenue primarily through product sales across multiple channels. The company has strategically shifted toward direct-to-consumer online sales, which now represent approximately two-thirds of total revenue, while wholesale distribution accounts for the remaining third. Online sales occur primarily through Amazon, where the company has built subscriber bases exceeding 100,000 customers, as well as through its own e-commerce platforms. The wholesale channel involves selling products to retail partners including specialty nutrition stores, mass market retailers, and fitness chains. However, this channel has faced challenges due to declining foot traffic in physical stores and specific issues with major wholesale partners like GNC. The company's business model benefits from the recurring nature of supplement consumption, as customers typically reorder products regularly. This is particularly evident in their Amazon subscriber model, where customers receive automatic shipments of their preferred products. The subscription model provides predictable revenue streams and higher customer lifetime value. Several factors influence the company's profitability margins. Positive margin drivers include the shift toward higher-margin online sales, economies of scale in manufacturing and procurement, and the ability to optimize advertising spend on digital platforms. The company has improved gross margins from approximately 40% to over 43% through operational improvements and channel mix optimization. Margin pressures come from ingredient cost inflation, potential tariff impacts on imported raw materials, increasing digital advertising costs on platforms like Amazon, and competitive pricing pressure in the crowded supplement market. The company mitigates some of these risks by working with manufacturers to source ingredients from multiple countries and by forward-purchasing key ingredients during favorable pricing periods.
Competitive moat
FitLife Brands operates in a highly competitive nutritional supplement market with relatively low barriers to entry, suggesting a limited economic moat. The company's competitive advantages are primarily operational rather than structural. Its strongest moat elements include established brand recognition in specific niches, particularly the Dr. Tobias brand's position in digestive health supplements, and its substantial Amazon subscriber base of over 100,000 customers, which provides some customer retention and predictable revenue. The company has developed expertise in digital marketing and e-commerce optimization, particularly on Amazon's platform, which gives it some operational advantages over traditional supplement companies. Additionally, its diversified brand portfolio provides some protection against individual product or category declines. However, the nutritional supplement industry faces significant competitive threats. New entrants can easily launch products through contract manufacturers and leverage the same digital marketing channels. Established players like Glanbia, Optimum Nutrition, and other major supplement companies have greater resources for marketing, research and development, and retail relationships. Private label products from retailers like Amazon's own brands can undercut branded products on price. The regulatory environment also poses risks, as the FDA could implement stricter regulations on supplement claims and manufacturing, potentially favoring larger companies with more compliance resources. The industry's reliance on digital advertising platforms creates vulnerability to algorithm changes and increasing advertising costs. Overall, FitLife Brands' moat appears narrow, relying primarily on brand recognition, customer relationships, and operational efficiency rather than structural competitive advantages. The company's success depends largely on execution in marketing, product development, and strategic acquisitions rather than sustainable competitive barriers.
Risks & safety
FitLife Brands demonstrates a reasonable margin of safety with solid financial fundamentals, though some metrics warrant attention. • Liquidity and Solvency: Strong current ratio of 1.64x with $5.9 million in cash and short-term investments. Total debt-to-equity ratio of 0.13x indicates minimal leverage risk. Free cash flow of $2.3 million in Q1 2025 shows positive cash generation. • Profitability: Consistent profitability with net income of $2.0 million in Q1 2025 and $9.0 million for full year 2024. EBITDA margins around 18-19% demonstrate operational efficiency. • Valuation Metrics: Trading at 13.8x P/E ratio and 9.3x EV/EBITDA, which appears reasonable for a growing consumer products company. Price-to-book ratio of 2.86x is elevated but not excessive given the company's ROE of 5.2%. • Growth and Stability: Revenue has grown from $28.8 million in 2022 to $64.5 million in 2024, though Q1 2025 showed a 4% decline. The shift toward higher-margin online sales provides some stability. • Other Considerations: The company's small size ($134 million market cap) creates liquidity risk and vulnerability to market volatility. Dependence on Amazon for a significant portion of sales creates platform risk. Potential tariff impacts on ingredient costs could pressure margins.
Recent development
Over the past few years, FitLife Brands has undergone significant strategic transformation through acquisitions and operational pivots. The company completed two major acquisitions: Mimi's Rock Corp in 2023 for $17 million, which brought the successful Dr. Tobias brand and established the company's strong Amazon presence, and MusclePharm's assets through bankruptcy proceedings, adding a well-known sports nutrition brand to the portfolio. The most significant strategic shift has been the transition from wholesale-dependent sales to direct-to-consumer online channels. Online sales now represent approximately two-thirds of total revenue, compared to a much smaller percentage just a few years ago. This shift has been driven by declining foot traffic in physical retail stores and the company's success in building Amazon subscriber bases across its brands. Product development has accelerated across all segments. The company launched new MusclePharm protein bars with multiple flavors, introduced ready-to-drink protein beverages, and is preparing to launch new products under the Dr. Tobias and Legacy FitLife brands. The MusclePharm brand has undergone rebranding with updated packaging and renewed focus on rebuilding retail relationships. The company has also improved its financial position substantially, reducing net debt by $6.5 million in 2024 and achieving gross margin expansion from approximately 40% to over 43%. Management has indicated continued interest in strategic acquisitions, with the financial capacity to pursue transactions in the $30-35 million range, focusing on brands with good fundamentals but financial challenges. Operationally, the company has invested heavily in digital marketing optimization and supply chain improvements, including diversifying ingredient sourcing to mitigate potential tariff impacts and forward-purchasing strategies to manage cost inflation.
FTLF company profile · for informational purposes only — not investment advice.
Track FTLF with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free